secwatch / observer
8-K filed January 9, 2023, 6:59 PM ET ticker ATRC CIK 0001323885
earnings confidence high sentiment positive materiality 0.70

AtriCure reports Q4 2022 preliminary revenue $88M (+20% YoY); guides 2023 rev $380-387M

AtriCure, Inc.

2022-FY EPS reported -$1.02 revenue$330,379,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AtriCure, Inc. reported the fourth quarter and full year ended December 31, 2022 results: revenue $330.4 million, EPS approximately $1.10 to $1.12. Guidance initiated.

Period
the fourth quarter and full year ended December 31, 2022
Revenue
$330.4 million
EPS
approximately $1.10 to $1.12
Guidance
initiated
Result
preliminary results
Exact text from the filing
Preliminary, unaudited revenue for fourth quarter 2022 is expected to be approximately $88.0 million, reflecting growth of approximately 20% over the fourth quarter of 2021 (21% on a constant currency basis).
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AtriCure, Inc. reported the fourth quarter and full year ended December 31, 2022 results: revenue $330.4 million, EPS approximately $1.10 to $1.12. Guidance initiated.

Period
the fourth quarter and full year ended December 31, 2022
Revenue
$330.4 million
EPS
approximately $1.10 to $1.12
Guidance
initiated
Result
preliminary results
Exact text from the filing
Preliminary, unaudited revenue for full year 2022 is expected to be $330.4 million, reflecting growth of approximately 20% over full year 2021 (22% on a constant currency basis).
View on SEC.gov

Browse all earnings releases →

AtriCure, Inc. filing history →

Source: SEC EDGAR
accession 0001323885-23-000008
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.